Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-κB activation and cyclooxygenase-2 expression in human breast epithelial cells: Cysteine 179 of IKKβ as a potential target

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1442-1449

  Son, Pil Soon ^a   Park, Sin Aye ^a   Na, Hye Kyung ^b   Jue, Dae Myung ^c   Kim, Sanghee ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

^b Sungshin Women's University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALANINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; CYSTEINE; DITHIOTHREITOL; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; OXYRESVERATROL; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PICEATANNOL; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; CELL TRANSFORMATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG TARGETING; ENZYME INDUCTION; ENZYME INHIBITION; GENE INDUCTION; GRAPE; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHUBARB; SIGNAL TRANSDUCTION; SUGARCANE;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYSTEINE; EPITHELIAL CELLS; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; PHENOLS; PHORBOL ESTERS; STILBENES; WOUND HEALING;

EID: 77955373319     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq099     Document Type: Article

References (49)

1. Mayer,A.M. (2006) Polyphenol oxidases in plants and fungi: going places? A review. Phytochemistry, 67, 2318-2331.
2. Fremont,L. (2000) Biological effects of resveratrol. Life Sci., 66, 663-673.
3. Rocha-Gonzalez,H.I. et al. (2008) Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci. Ther., 14, 234-247.
4. Bertelli,A.A. et al. (2009) Grapes, wines, resveratrol and heart health. J. Cardiovasc. Pharmacol., 54, 468-476.
5. de la Lastra,C.A. et al. (2005) Resveratrol as an anti-inflammatory and antiaging agent: mechanisms and clinical implications. Mol. Nutr. Food Res., 49, 405-430.
6. Jang,M. et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
7. Brisdelli,F. et al. (2009) Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr. Drug Metab., 10, 530-546.
8. Kundu,J.K. et al. (2008) Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett., 269, 243-261.
9. Wenzel,E. et al. (2005) Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res., 49, 472-481.
10. Roupe,K.A. et al. (2006) Pharmacometrics of stilbenes: seguing towards the clinic. Curr. Clin. Pharmacol., 1, 81-101.
11. Kim,Y.H. et al. (2008) Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis. Int. Immunopharmacol., 8, 1695-1702.
12. Yokozawa,T. et al. (2007) Piceatannol inhibits melanogenesis by its antioxidative actions. Biol. Pharm. Bull., 30, 2007-2011.
13. Ashikawa,K. et al. (2002) Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol., 169, 6490-6497.
14. Aggarwal,B.B. et al. (2006) Inflammation and cancer: how hot is the link? Biochem. Pharmacol., 72, 1605-1621.
15. Aggarwal,B.B. et al. (2009) Inflammation and cancer: how friendly is the relationship for cancer patients? Curr. Opin. Pharmacol., 9, 351-369.
16. Prescott,S.M. et al. (2000) Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta, 1470, M69-M78.
17. Karin,M. et al. (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol., 12, 85-98.
18. Hacker,H. et al. (2006) Regulation and function of IKK and IKK-related kinases. Sci. STKE, 2006, re13.
19. Perkins,N.D. (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol., 8, 49-62.
20. Nishi,T. et al. (2002) Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J. Biol. Chem., 277, 44548-44556.
21. Byun,M.S. et al. (2006) Cysteine-179 of IkappaB kinase beta plays a critical role in enzyme activation by promoting phosphorylation of activation loop serines. Exp. Mol. Med., 38, 546-552.
22. Kapahi,P. et al. (2000) Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J. Biol. Chem., 275, 36062-36066.
23. Jeon,K.I. et al. (2000) Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. J. Immunol., 164, 5981-5989.
24. Kim,B.H. et al. (2007) Artemisolide is a typical inhibitor of IkappaB kinase beta targeting cysteine-179 residue and down-regulates NF-kappaBdependent TNF-alpha expression in LPS-activated macrophages. Biochem. Biophys. Res. Commun., 361, 593-598.
25. Rossi,A. et al. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature, 403, 103-108.
26. Straus,D.S. et al. (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl Acad. Sci. USA, 97, 4844-4849.
27. Ha,K.H. et al. (2009) N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA. Biochemistry, 48, 7271-7278.
28. Harikumar,K.B. et al. (2009) Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood, 113, 2003-2013.
29. Bharti,A.C. et al. (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101, 1053-1062.
30. Cernuda-Morollon,E. et al. (2001) 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J. Biol. Chem., 276, 35530-35536.
31. Park,S.A. et al. (2009) 4-Hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkB kinase: potential role of reactive oxygen species. Cancer Res., 69, 2416-2424.
32. Doll,R. et al. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
33. Surh,Y.J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 3, 768-780.
34. Willett,W.C. (1995) Diet, nutrition, and avoidable cancer. Environ. Health Perspect., 103 (suppl. 8), 165-170.
35. Dorai,T. et al. (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett., 215, 129-140.
36. Na,H.K. et al. (2006) Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Mol. Carcinog., 45, 368-380.
37. Ferrigni,N.R. et al. (1984) Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J. Nat. Prod., 47, 347-352.
38. Dang,O. et al. (2004) Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes. Shock, 21, 470-475.
39. Liu,D. et al. (2009) Piceatannol inhibits phorbol ester-induced NF-kappa B activation and COX-2 expression in cultured human mammary epithelial cells. Nutr. Cancer, 61, 855-863.
40. Lee,Y.M. et al. (2009) Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity. Cancer Lett., 285, 166-173.
41. Jang,Y.J. et al. (2009) Piceatannol attenuates 4-hydroxynonenal-induced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase. Ann. N. Y. Acad. Sci., 1171, 176-182.
42. Nakamura,Y. et al. (2003) Pivotal role of electrophilicity in glutathione S-transferase induction by tert-butylhydroquinone. Biochemistry, 42, 4300-4309.
43. Satoh,T. et al. (2008) Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem., 104, 1116-1131.
44. Satoh,T. et al. (2007) Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci., 30, 37-45.
45. Kim,E.H. et al. (2006) 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem. Pharmacol., 72, 1516-1528.
46. Pandey,M.K. et al. (2008) Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res., 68, 5370-5379.
47. Zhang,Y. et al. (2007) Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. Metabolism, 56, 887-894.
48. Samuni,A.M. et al. (2003) Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants. Proc. Natl Acad. Sci. USA, 100, 5390-5395.
49. Klimowicz,A.C. et al. (2009) The phytochemical piceatannol induces the loss of CBL and CBL-associated proteins. Mol. Cancer Ther., 8, 602-614.